Kenneth J. Zuerblis, EVP, Chief Financial Officer at SAVIENT PHARMACEUTICALS INC (SVNT), bought 2,000 shares at $2.35 ($5K) on 2011-11-18, disclosed to the SEC on 2011-11-21.
Open-market purchase of $5k SVNT by EVP, Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| SVNT | BUY | 2011-09-16 | $20K | — | Filing → |